Steve Valiquette
Stock Analyst at Barclays
(1.51)
# 3,499
Out of 5,154 analysts
147
Total ratings
47.42%
Success rate
-1.95%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $8 → $9.5 | $14.73 | -35.51% | 6 | Nov 10, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $5.12 | +134.38% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $931.35 | -33.86% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $2.29 | +293.01% | 7 | Mar 1, 2024 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $18.39 | +30.51% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $78.69 | +9.29% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $43.27 | +96.44% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $534.47 | -43.87% | 4 | Jun 28, 2023 | |
| LTC LTC Properties | Maintains: Underweight | $35 → $34 | $38.16 | -10.90% | 3 | May 3, 2023 | |
| THC Tenet Healthcare | Maintains: Overweight | $70 → $105 | $241.40 | -56.50% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $84.96 | -35.26% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $20.02 | -35.06% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $196.96 | -27.90% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $36.26 | -86.21% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $107.63 | -47.04% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $205.05 | -60.01% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.41 | +3.39% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $47.07 | -34.14% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $147.71 | +153.88% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $39.37 | -51.74% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $180.75 | +215.35% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $216.02 | -70.37% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $281.27 | +10.21% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $288.77 | +95.66% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $1.73 | +4,235.26% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $9.53 | +99.37% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.41 | +193.26% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $7.26 | +175.48% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $79.80 | +225.81% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8 → $9.5
Current: $14.73
Upside: -35.51%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $5.12
Upside: +134.38%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $931.35
Upside: -33.86%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $2.29
Upside: +293.01%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $18.39
Upside: +30.51%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $78.69
Upside: +9.29%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $43.27
Upside: +96.44%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $534.47
Upside: -43.87%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $38.16
Upside: -10.90%
Tenet Healthcare
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $241.40
Upside: -56.50%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $84.96
Upside: -35.26%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $20.02
Upside: -35.06%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $196.96
Upside: -27.90%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $36.26
Upside: -86.21%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $107.63
Upside: -47.04%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $205.05
Upside: -60.01%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $17.41
Upside: +3.39%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $47.07
Upside: -34.14%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $147.71
Upside: +153.88%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $39.37
Upside: -51.74%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $180.75
Upside: +215.35%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $216.02
Upside: -70.37%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $281.27
Upside: +10.21%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $288.77
Upside: +95.66%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $1.73
Upside: +4,235.26%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $9.53
Upside: +99.37%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.41
Upside: +193.26%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $7.26
Upside: +175.48%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $79.80
Upside: +225.81%